Agilent’s Q4 Revenue Rise 8.9 Percent as Life Science Counters Flat Electronics Sales | GenomeWeb
Pushed along by 30-percent growth in life sciences receipts, Agilent last week said overall revenues rose 8.9 percent for its fiscal fourth quarter.
During the quarter ended Oct. 31, the company posted overall revenues of $1.45 billion, up from $1.33 billion a year ago. The climb came almost exclusively from Agilent’s Bio-Analytical Measurement division, which houses the company’s proteomics tools. During the quarter receipts in the division increased 24 percent to $558 million from $450 million a year ago.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.